References
-
Fernandez-Checa, J. C. et al. Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced liver injury network [PRO-EURO-DILI-NET]. J. Hepatol. 75, 935–959 (2021).
-
Kuna, L. et al. Models of drug induced liver injury (DILI) – Current issues and future perspectives. Curr. Drug Metab. 19, 830–838 (2018).
-
Susukida, T., Sekine, S., Nozaki, M., Tokizono, M. & Ito, K. Prediction of the clinical risk of Drug-Induced cholestatic liver injury using an in vitro sandwich cultured hepatocyte assay. Drug Metab. Dispos. 43, 1760–1768 (2015).
-
Bonn, B., Svanberg, P., Janefeldt, A., Hultman, I. & Grime, K. Determination of human hepatocyte intrinsic clearance for slowly metabolized compounds: comparison of a primary hepatocyte/Stromal cell Co-culture with plated primary hepatocytes and HepaRG. Drug Metab. Dispos. 44, 527–533 (2016).
-
Macko, P., Palosaari, T. & Whelan, M. Extrapolating from acute to chronic toxicity in vitro. Toxicol. Vitro. 76, 105206 (2021).
-
McKim, J. Jr Building a tiered approach to in vitro predictive toxicity screening: A focus on assays with in vivo relevance. Comb. Chem. High. Throughput Screen. 13, 188–206 (2010).
-
Wilkening, S. & Bader, A. Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2. J. Biochem. Mol. Toxicol. 17, 207–213 (2003).
-
Bell, C. C. et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci. Rep. 6, 25187 (2016).
-
Hu, H. et al. Long-Term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175, 1591–1606e19 (2018).
-
Riede, J., Wollmann, B. M., Molden, E. & Ingelman-Sundberg, M. Primary human hepatocyte spheroids as an in vitro tool for investigating drug compounds with low hepatic clearance. Drug Metab. Dispos. 49, 501–508 (2021).
-
Ueyama-Toba, Y. et al. Development of a hepatic differentiation method in 2D culture from primary human hepatocyte-derived organoids for pharmaceutical research. iScience 27, 110778 (2024).
-
Bale, S. S. et al. Long-Term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cells. Tissue Eng. Part. C Methods. 21, 413–422 (2015).
-
Katsuda, T. et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. eLife 8, e47313 (2019).
-
Jellali, R. et al. Long-term human primary hepatocyte cultures in a microfluidic liver biochip show maintenance of mRNA levels and higher drug metabolism compared with petri cultures. Biopharm. Drug Dispos. 37, 264–275 (2016).
-
Byeon, J. H., Jung, D. J., Han, H. J., Son, W. C. & Jeong, G. S. Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip. Front. Cell. Dev. Biol. 12, 1452485 (2024).
-
Kaur, I. et al. Primary hepatocyte isolation and cultures: technical Aspects, challenges and advancements. Bioengineering 10, 131 (2023).
-
Mun, S. J. et al. Long-Term expansion of functional human pluripotent stem Cell-Derived hepatic organoids. Int. J. Stem Cells. 13, 279–286 (2020).
-
Shinohara, M. et al. Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system. Sci. Rep. 11, 5437 (2021).
-
Shoemaker, J. T. et al. A 3D cell culture Organ-on-a-Chip platform with a breathable hemoglobin analogue augments and extends primary human hepatocyte functions in vitro. Front. Mol. Biosci. 7, 568777 (2020).
-
Hu, Y. et al. Research progress and application of liver organoids for disease modeling and regenerative therapy. J. Mol. Med. 102, 859–874 (2024).
-
Sugahara, G. et al. Long-term cell fate and functional maintenance of human hepatocyte through Stepwise culture configuration. FASEB J 37, (2023).
-
Handin, N. et al. Conditions for maintenance of hepatocyte differentiation and function in 3D cultures. iScience 24, 103235 (2021).
-
Horiuchi, S. et al. Formation of functional, extended bile canaliculi, and increased bile acid production in sandwich-cultured human cryopreserved hepatocytes using commercially available culture medium. Arch. Toxicol. 98, 2605–2617 (2024).
-
Liu, Y. et al. Generation and characterization of mature hepatocyte organoids for liver metabolic studies. J. Cell. Sci. 137, jcs261961 (2024).
-
Meneses-Lorente, G. et al. Utility of Long-Term cultured human hepatocytes as an in vitro model for cytochrome P450 induction. Drug Metab. Dispos. 35, 215–220 (2007).
-
Tong, Y. et al. Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research. Sci. Rep. Nat. Publ Group. 14, 10846 (2024).
-
Chen, Y. et al. Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro. Arch. Toxicol. 95, 2431–2442 (2021).
-
Katsuda, T. et al. Long-term maintenance of functional primary human hepatocytes using small molecules. FEBS Lett. 594, 114–125 (2019).
-
Xiang, C. et al. Long-term functional maintenance of primary human hepatocytes in vitro. Science 364, 399–402 (2019).
-
Cicchini, C. et al. Molecular mechanisms controlling the phenotype and the EMT / MET dynamics of hepatocyte. Liver Int. 35, 302–310 (2015).
-
LeCluyse, E. L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur. J. Pharm. Sci. 13, 343–368 (2001).
-
Zhong, Y., Yu, J. S., Wang, X., Binas, B. & Yoo, H. H. Chemical-based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: comparison with the spheroid model. FASEB J 35, (2021).
-
Bell, C. C. et al. Comparison of hepatic 2D sandwich cultures and 3D spheroids for Long-term toxicity applications: A multicenter study. Toxicol. Sci. 162, 655–666 (2018).
-
Jigorel, E., Le Vee, M., Boursier-Neyret, C., Parmentier, Y. & Fardel, O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-Sensing receptors in primary human hepatocytes. Drug Metab. Dispos. 34, 1756–1763 (2006).
-
Luttringer, O. et al. Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. Biochem Pharmacol. 1637–1650 (2002).
-
Mickols, E. et al. OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids. Sci. Rep. Nat. Publ Group. 14, 17334 (2024).
-
Ebner, T., Ishiguro, N. & Taub, M. E. The use of transporter probe drug cocktails for the assessment of transporter-Based drug–Drug interactions in a clinical Setting—Proposal of a four component transporter cocktail. J. Pharm. Sci. 104, 3220–3228 (2015).
-
Guo, C., Brouwer, K. L. R., Brouwer, K. R., Stewart, P. W. & Mosley, C. Probe cocktail to assess transporter function in Sandwich-Cultured human hepatocytes. J. Pharm. Pharm. Sci. 22, 567–575 (2019).
-
Järvinen, E., Hammer, H. S., Pötz, O., Ingelman-Sundberg, M. & Stage, T. B. 3D spheroid primary human hepatocytes for prediction of cytochrome P450 and drug transporter induction. Clin. Pharmacol. Ther. 113, 1284–1294 (2023).
-
Wegler, C. et al. Global variability analysis of mRNA and protein concentrations across and within human tissues. NAR Genomics Bioinforma. 2, lqz010 (2020).
